Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals, Inc. (ELOX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $53M; returns 1 day -2.4%, 1 week -1.8%.

Eloxx Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel RNA-modulating genetic therapies for rare and ultra-rare diseases caused by premature stop codons. The company leverages its proprietary TURBO-ZM™ chemistry platform and Eukaryotic Ribosomal Selective Glycosides (ERSGs) to restore functional protein production.

Groups ELOX belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Recent IPOs
• Biopharmaceutical
• Rare Diseases
• Healthcare
• Cystic Fibrosis Therapies
• Clinical Stage
• Dermatology
• Nephrology
• Pharmaceuticals

ELOX financial model: income statement, cash flow and balance sheet